CYTO News
Archived Headlines
- Ear biotech Otonomy sets terms for $80 million IPO 08/01/14
- 22 US IPOs planned for the week of Jul 28 07/28/14
- July biotech blitz and the upcoming eye, ear and nose IPOs 07/22/14
- Ear disease biotech Auris Medical sets terms for $76 million IPO 07/21/14
- Ear disease biotech Otonomy files for an $86 million IPO 07/11/14
See more
US IPO Pricing Recap: 7 IPOs see heavy discounts and positive trading
Seven companies went public this past week; only one (iDreamSky, DSKY) priced above its midpoint while just one other IPO (Ryerson, RYI) ended the week negative. Broader markets remain rocky, dampening the demand for initial public offerings ahead...read more
Auris Medical prices IPO at $6
Auris Medical, a biotech developing treatments for tinnitus and other inner ear disorders, raised $56 million by offering 9.4 million shares at $6, consistent with the revised terms filed with the SEC on Tuesday. Auris Medical plans to list on the NASDAQ under...read more
Auris Medical slashes proposed price to $6, increases insider buying; market cap drops 40%
Auris Medical, a biotech developing treatments for tinnitus and other inner ear disorders, lowered the proposed deal size for its upcoming IPO on Tuesday. The Zug, Switzerland-based company now plans to raise $56 million by offering 9.4 million shares at a price...read more
11 US IPOs planned for the week of Aug 4
11 offerings are scheduled to kick off the first full week of August, a month that should see a sharp slowdown in IPO activity following the busiest month since 2000 (July had 34 IPOs, ...read more